The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMMUNORARE5: A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The Gestational Trophoblastic Tumors Cohort.
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; Eisai; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Pharma&; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); NOVARTIS (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech; SEAGEN
 
Alexandra Leary
Honoraria - Gerson Lehrman Group; Medscape; peervoice
Consulting or Advisory Role - Abbvie (Inst); Apmonia Therapeutics (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Merck Serono (Inst); MSD (Inst); PEGASCY; Pharmend (Inst); Seagen (Inst); Tesaro (Inst); zentalis (Inst)
Research Funding - Adaptimmune (Inst); AstraZeneca (Inst); Inivata (Inst); MSD Oncology (Inst); OSE Immunotherapeutics (Inst); owkin (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Oseimmuno; Tesaro
 
Mathieu Jamelot
Honoraria - Astellas Pharma; Ipsen; Janssen; Merck; Novartis
Travel, Accommodations, Expenses - Ipsen
 
Pauline Parent
No Relationships to Disclose
 
Coriolan Lebreton
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; MSD Oncology; Regeneron
Consulting or Advisory Role - Abbvie; AstraZeneca
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD Oncology
 
Laurence Gladieff
Consulting or Advisory Role - GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD Oncology
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai; Exact Sciences (Inst); Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology (Inst); Novartis (Inst); Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; seagen
 
Magali Provansal
No Relationships to Disclose
 
Marie Meurer
No Relationships to Disclose
 
Thibault De La Motte Rouge
Honoraria - AstraZeneca; Gilead Sciences; GlaxoSmithKline; MSD Oncology; Mylan; Pfizer; Roche/Genentech; Sanofi; Tesaro
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; Eisai; Gilead Sciences; GlaxoSmithKline; MSD Oncology (Inst); Mylan; Pfizer; Regeneron; Roche; Sanofi; Tesaro
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Gilead Sciences; MSD; Pfizer; Roche
 
Veronique D'hondt
Travel, Accommodations, Expenses - Lilly; MSD; Novartis; Pfizer
 
Lauriane Eberst
No Relationships to Disclose
 
Cecile Vicier
Honoraria - BMSi; Ipsen; seagen
Consulting or Advisory Role - BMSi; Daiichi Sankyo/Astra Zeneca; Novartis; Owkin; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Pascale Tomasini
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol Myers Squibb Foundation; Daiichi Sankyo Europe GmbH; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb/Pfizer; Daiichi Sankyo Europe GmbH; Takeda
 
Diego Tosi
Consulting or Advisory Role - Brenus Pharma; Mabqi; Tes Pharma
Research Funding - Bayer; Ipsen
Patents, Royalties, Other Intellectual Property - I have a pending patent on a new drug combination for prostate cancer treatment
Travel, Accommodations, Expenses - Advanced Accelerator Applications; AstraZeneca; Biogen (I); BMS; Ipsen; Medusas (I); Novartis; Pfizer
(OPTIONAL) Uncompensated Relationships - Brenus Pharma; Phost'in
 
Sara Calattini
No Relationships to Disclose
 
Touria Hajri
No Relationships to Disclose
 
Vérane Schwiertz
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene
 
Fabien Subtil
No Relationships to Disclose
 
Pierre-Adrien Bolze
Consulting or Advisory Role - Merck Serono